GSK3β(high)/NFATc1(high) subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair Pancreas Diseases Share: Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me Forgot password? Click here
Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me